Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC

Clinical trial NCT07026474 · RECRUITING

Trial details

NCT number: NCT07026474
Sponsor: Universität des Saarlandes
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Recurrent Head and Neck Squamous Cell Carcinoma

Start date: 2025-10-30
Primary completion: 2032-12-01
Enrollment: 214

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.